
Precision Health: Investing in the Future of Personalized Medicine and Global Healthcare
At the Precision Health Summit 2024, leaders examine the immense investment potential in precision health, a field at the intersection of AI, genomics, and personalized medicine. Panelists Martin Alexander Gershon of Endeavor Fund, Arda Ural of EY, Pooja Majmudar of Keles, and Allan Gobbs of ATEM Capital emphasize the sector’s need for strategic, long-term commitment to drive meaningful financial returns and societal impact. Addressing resilience, regulatory support, and cross-border partnerships, they explore how precision health extends beyond treatments to tackle broader health determinants, marking it as a transformative investment frontier for growth-oriented leaders in global healthcare.
Information
Program:
Precision Health Summit
Released:
2024
Languages
Audio:
English
Subtitles:
English
Accessibility
CC:
Closed caption (CC) available in English
Transcript:
Video transcript available in English